posted
Torbay Holdings Inc: Clinical Research Results Indicates That AirO2bic Mouse Usage Prevent & Remediate Carpal Tunnel Syndrome Tuesday June 7, 2:53 pm ET
MINEOLA, N.Y.--(BUSINESS WIRE)--June 7, 2005--Torbay Holdings, Inc. (OTCBB:TRBY.OB - News) today announced that a clinical study at a Rehabilitation and Electrodiagnostic Medicine Clinic in Florida (details to be released upon completion of the study) indicates that the use of the company's AirO2bic (pronounced aerobic) grip-less mouse may both prevent and remediate Carpal Tunnel Syndrome. This initial Pilot study was designed to evaluate the parameters to be used in a larger population study that will follow, with the objective to investigate the impact of the use of the AirO2bic mouse upon Carpal Tunnel Syndrome (CTS) and non-CTS subjects. ADVERTISEMENT
The study employs the measurement of Nerve Conduction Velocity (NCV), which is a diagnostic test for CTS. NCV measures the speed at which an electrical impulse passes down a nerve. The nerves of healthy subjects conduct impulses more rapidly than those with CTS.
NCV measurements were made upon the test subjects that indicated that some subjects were positive for CTS and some were within the normal range of healthy subjects. Both groups then received an AirO2bic mouse, which was the only change in their working environment and NCV measurements were made at monthly intervals.
After only two months into the study the results have surprised (even) the company and the M.D. performing the research. Within a month of using the AirO2bic mouse CTS positive subjects demonstrated measurable and significant improvement in their NCV values, while NCV normal subjects remained "NCV normal". After two months CTS positive subjects have continued to improve and several now have normal nerve conduction velocities. All original NCV normal subjects continue to remain stable and normal.
The interim study report states, "The subjects with CTS have in this study improved their distal latency with the use of the AirO2bic mouse as the only intervention at their workstations." "AirO2bic mouse has shown stabilization of CTS and improvement as well". It concludes by saying "Congratulations this is very exciting as we now have a new tool, the AirO2bic mouse, to offer computer users to prevent CTS as well as improve (persons with) the syndrome."
Tom Large, President & CEO of TRBY stated: "This pilot study clinically substantiates and validates our mouse design and is a testament to the benefits of mousing without grip. This is the first research to our knowledge that demonstrates that avoiding the use of grip when mousing has a positive clinical outcome for persons with CTS. This data must now contribute towards the debate that gripping computer mice is a factor in the development of CTS as it proves that not gripping them provides for improvement in those with that condition. This study also indicates the preventative capability that a grip-less posture may afford those who are as yet unimpaired or exhibiting CTS. To date, other studies have been unable to conclusively confirm that ordinary computer mice cause CTS due to their being so many variables in other study's paramters. This study however demonstrated that changing only one variable, from an industry standard computer mouse, lead to a rapid and clinically measurable improvement in CTS sufferers, which, in our opinion, is compelling evidence supporting our assertion that grip requiring mice are complicit in the development of CTS."
"The estimated number of computers in use in 2001 was some 500M. Fundamental mouse product design in the injury pool {or the mass market} has remained substantially unchanged since the mouse was invented, some 40 years ago. However, the pattern and extent of their use, and the prevalence of injury, have not." In the US alone total estimates for CTS in 1995 were 5M cases. Non-surgery medical cost estimates of $15,000+ per case and some $30,000 to $100,000 per year in workers compensation have been reported. The American Association of Orthopaedic Surgeons estimate annual cost of $27 billion in CTS medical treatment and lost income. An extract from a 2004 National Institute of Occupational Safety and Health (NIOSH) report in regard to the State of California CTS statistics: 'Number of CTS cases in California by type of job activity, 1998-2000: Among the cases sampled, computing (data entry) activities consistently accounted for nearly half of all CTS cases in California for each of the 3 years during 1998-2000'.O
"The extent of the industry's response to the computer related CTS debate and other disorders associated with extensive computer use to date, has been to talk about "product comfort" and to provide ergonomic advice while placing usage warnings and disclaimers upon input device products. In a new development we have firsthand knowledge, in that a workers compensation claim is citing a major input device manufacturer's product disclaimer as evidence for a correlation between their injury and their computer use. This has been the link that in the past has been considered lacking when making computer related injury case determinations. If such a strategy were to be successful then the impact upon workers compensation claims, employers and their insurers, could be significant as the provision of products which carry such disclaimers could, in our opinion, carry with it heightened corporate impact as a consequence of their use."
"We are currently reviewing recent research that seems to indicate that our empirical determination of the impact of anaerobic (low oxygen) conditions in active muscle cells could be a key factor in the initiation and propagation of impairment and injury in those who use computers extensively. We believe this position is now further supported by these findings."
"Based upon the feedback of success with our products that we receive from a significant number of users, including planned CTS surgery being cancelled as a result of the use of our mouse product, we have initiated a product development program in preparation for what we believe will be a more informed understanding of the issues relating to extensive computer use. Such an understanding will require a market initiative that employers may find difficult to ignore as it will seek to better manage the issues that research is now indicating are the primary challenges to computer users. We will shortly launch a new software product that will spearhead our contribution towards this initiative and, we believe, will redefine our mission and purpose and extend the market potential of some of our products to all computers and users."
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this release that are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause results to differ materially from those expressed in the forward-looking statements, including but not limited to, certain delays and risks detailed from time to time in the company's filings with the Securities and Exchange Commission.
For More Information Contact:
-------------------------------------------------------------------------------- Contact: Torbay Holdings Inc. Tom Large, 516-747-5955 President and CEO pr@trby.com www.trby.com www.aerobicmouse.com
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
